These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9103337)

  • 1. Bioequivalence of levothyroxine preparations for treatment of hypothyroidism.
    Spigelman MK
    JAMA; 1997 Apr; 277(15):1199-200. PubMed ID: 9103337
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioequivalence of levothyroxine preparations: industry sponsorship and academic freedom.
    Eckert CH
    JAMA; 1997 Apr; 277(15):1200-1. PubMed ID: 9103338
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
    Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
    JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levothyroxine bioequivalence.
    Schellhase KG; Ellsworth A
    J Fam Pract; 1997 Jul; 45(1):23-4. PubMed ID: 9228909
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioequivalence of generic preparations of levothyroxine.
    Toft A
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):603; author reply 603-4. PubMed ID: 19508682
    [No Abstract]   [Full Text] [Related]  

  • 6. Levothyroxine: therapeutic use and regulatory issues related to bioequivalence.
    Wartofsky L
    Expert Opin Pharmacother; 2002 Jun; 3(6):727-32. PubMed ID: 12036412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levothyroxine bioequivalence.
    Katz MD; Scherger JE
    J Fam Pract; 1998 Feb; 46(2):108-9. PubMed ID: 9487307
    [No Abstract]   [Full Text] [Related]  

  • 8. Interchangeability of levothyroxine preparations.
    Ridgway EC
    Am J Med; 1996 Feb; 100(2):245-6; author reply 246-7. PubMed ID: 8629666
    [No Abstract]   [Full Text] [Related]  

  • 9. Interchangeability of levothyroxine preparations.
    Davies TF
    Am J Med; 1996 Feb; 100(2):245; author reply 246-7. PubMed ID: 8629665
    [No Abstract]   [Full Text] [Related]  

  • 10. Interchangeability of levothyroxine preparations.
    DeGroot LJ
    Am J Med; 1996 Feb; 100(2):244-5; author reply 246-7. PubMed ID: 8629664
    [No Abstract]   [Full Text] [Related]  

  • 11. The emergence of levothyroxine as a treatment for hypothyroidism.
    Hennessey JV
    Endocrine; 2017 Jan; 55(1):6-18. PubMed ID: 27981511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levothyroxine sodium tablets: chemical equivalence and bioequivalence.
    Curry SH; Gums JG; Williams LL; Curry RW; Wolfson BB
    Drug Intell Clin Pharm; 1988; 22(7-8):589-91. PubMed ID: 3046889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
    Green WL
    AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence of thyroid preparations: the final word?
    Gibaldi M
    AAPS J; 2005; 7(1):E59-60. PubMed ID: 16493834
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo comparison of levothyroxine preparations.
    Ramos-Gabatin A; Jacobson JM; Young RL
    JAMA; 1982 Jan; 247(2):203-5. PubMed ID: 7053460
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment: therapeutic failure with levothyroxine brand interchange.
    Wolfson BB
    Ann Pharmacother; 1995 Oct; 29(10):1049-50. PubMed ID: 8845549
    [No Abstract]   [Full Text] [Related]  

  • 17. Levothyroxine and FDA bioequivalence ratings.
    Fox GN
    J Fam Pract; 2005 Feb; 54(2):179. PubMed ID: 15689298
    [No Abstract]   [Full Text] [Related]  

  • 18. Levothyroxine dosage and the limitations of current bioequivalence standards.
    Hennessey JV
    Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):474-5. PubMed ID: 16957756
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.
    Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F
    Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raloxifene causing malabsorption of levothyroxine.
    Siraj ES; Gupta MK; Reddy SS
    Arch Intern Med; 2003 Jun; 163(11):1367-70. PubMed ID: 12796075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.